Evaluation of Passive Immunity Induced by Immunisation Using Two Inactivated gE-deleted Marker Vaccines against Infectious Bovine Rhinotracheitis (IBR) in Calves.
BoHV-1
marker vaccines
passive immunity
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
04 Jan 2020
04 Jan 2020
Historique:
received:
09
10
2019
revised:
29
10
2019
accepted:
29
10
2019
entrez:
18
1
2020
pubmed:
18
1
2020
medline:
18
1
2020
Statut:
epublish
Résumé
Different types of vaccines against Infectious Bovine Rhinotracheitis (IBR) are commercially available. Among these, inactivated glycoprotein E (gE)-deleted marker vaccines are commonly used, but their ability to induce passive immunity is poorly known. Here, we evaluated the passive immunity transferred from dams immunised with commercial inactivated gE-deleted marker vaccines to calves. We vaccinated 12 pregnant cattle devoid of neutralising antibodies against Bovine alphaherpesvirus 1 (BoHV-1) and divided them into two groups with 6 animals each. Both groups were injected with a different inactivated gE-deleted marker vaccine administrated via intranasal or intramuscular routes. An additional 6 pregnant cattle served as the unvaccinated control group. After calving, the number of animals in each group was increased by the newborn calves. In the dams, the humoral immune response was evaluated before calving and, subsequently, at different times until post-calving day 180 (PCD180). In addition, the antibodies in colostrum, milk, and in serum samples from newborn calves were evaluated at different times until PCD180. The results indicated that inactivated glycoprotein E (gE)-deleted marker vaccines are safe and produce a good humoral immune response in pregnant cattle until calving and PCD180. Moreover, results showed that, in calf serum, passive immunity persists until PCD180.
Identifiants
pubmed: 31947899
pii: vaccines8010014
doi: 10.3390/vaccines8010014
pmc: PMC7157740
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Italian Ministry of Health
ID : Project RC IZSUM 05/2017
Références
Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):171-7
pubmed: 19027179
Vet Rec. 2003 May 31;152(22):681-6
pubmed: 12803395
Comp Immunol Microbiol Infect Dis. 2002 Jul;25(4):205-15
pubmed: 12135235
Prev Vet Med. 2017 Mar 1;138:1-8
pubmed: 28237224
Expert Rev Vaccines. 2007 Jun;6(3):369-80
pubmed: 17542752
Anim Health Res Rev. 2009 Jun;10(1):85-98
pubmed: 19558751
J Biotechnol. 1996 Jan 26;44(1-3):75-81
pubmed: 8717389
Am J Vet Res. 1978 Apr;39(4):607-10
pubmed: 206171
Vet Immunol Immunopathol. 2016 Jun;174:50-63
pubmed: 27185263
Res Vet Sci. 2014 Aug;97(1):32-7
pubmed: 24815344
Vet Microbiol. 2017 Jul;206:69-77
pubmed: 28377131
Vet Immunol Immunopathol. 2017 Mar;185:1-6
pubmed: 28241997
Infect Immun. 1984 Oct;46(1):25-33
pubmed: 6384045
J Am Vet Med Assoc. 2002 Sep 1;221(5):678-85
pubmed: 12216908
Viruses. 2019 Jan 02;11(1):
pubmed: 30609738
Vet Rec. 2001 Jul 28;149(4):105-8
pubmed: 11504200
Vaccine. 1997 Oct;15(14):1512-7
pubmed: 9330461
Comp Immunol Microbiol Infect Dis. 2002 Jan;25(1):29-41
pubmed: 11831745
J Am Vet Med Assoc. 2008 Jul 1;233(1):136-42
pubmed: 18593324
Can J Comp Med. 1985 Jan;49(1):10-4
pubmed: 2985214
Vet Ther. 2003 Summer;4(2):120-7
pubmed: 14506587
Am J Vet Res. 2015 Oct;76(10):913-20
pubmed: 26413830
Vet Microbiol. 2018 Jun;219:150-153
pubmed: 29778188
Transbound Emerg Dis. 2018 Dec;65(6):2043-2048
pubmed: 30054980
Comp Immunol Microbiol Infect Dis. 2011 Jan;34(1):3-10
pubmed: 19906427
Vet Rec. 1999 Feb 13;144(7):172-6
pubmed: 10097325
Vet Microbiol. 2011 Dec 29;154(1-2):14-22
pubmed: 22019288
Vaccine. 2004 Jan 26;22(5-6):643-9
pubmed: 14741155
Vaccine. 2015 Jan 15;33(4):549-58
pubmed: 25454086
Dev Comp Immunol. 2009 Mar;33(3):384-93
pubmed: 18761034
Can J Vet Res. 1987 Oct;51(4):452-9
pubmed: 2839276
Vet J. 2014 Sep;201(3):249-56
pubmed: 24954868
Ann N Y Acad Sci. 2004 Oct;1026:247-50
pubmed: 15604501